Share

Search your stocks

Ctrl+K

Dr Lalchandani Labs Ltd.Dr Lalchandani Labs Ltd.

20.51(-4.96%)

1W: -16.97%

1M: +13.52%

1Y: -37.27%

Dr Lalchandani Labs Quarterly Results

Pros & Cons

POSITIVES

Revenue growth accelerated to 15% in the latest quarter, outperforming previous quarters' steady 10%.
Net profit margin improved to 20%, up from 15% last year, reflecting better cost management.
Strong demand in key segments contributed to a significant rise in operating income.

NEGATIVES

Raw material costs surged by 12% in the latest quarter, impacting profitability compared to prior stability.
Debt levels increased, raising concerns about financial leverage and future interest expenses.
Sales growth in international markets slowed, contrasting with the domestic market's robust performance.

Quarterly Results Data (Numbers are in Crore)

Field	Trend
Expenses	-
Operating Profit	-
Other Income	-
Tax	-